S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Cresco Labs Stock Forecast, Price & News

-0.76 (-5.50 %)
(As of 03/5/2021 08:28 PM ET)
Today's Range
Now: $13.07
50-Day Range
MA: $14.41
52-Week Range
Now: $13.07
Volume2.63 million shs
Average Volume1.63 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells medical cannabis and medical cannabis products in the United States. It offers cannabis in flowers, live concentrates, and liquid live resins under the Cresco and Reserve brands; soft gels, tinctures, and lotions under the Remedi brand; gummies, fruit chews, hard sweets, and chocolates under the Mindy's brand; and vape pens, popcorn, shake, pre-rolls, and shorties under High supply brand. It operates 22 dispensaries in Illinois, Pennsylvania, Ohio, California, Nevada, Arizona, Massachusetts, and New York. The company is headquartered in Chicago, Illinois.
Cresco Labs logo


Two More Reasons To Bet Big On U.S. Cannabis
March 1, 2021 |  marketbeat.com
3 Cannabis Stocks to Buy and Hold
February 27, 2021 |  nasdaq.com
Agencies Look to Create Safeguards for Cannabis Use
February 25, 2021 |  prnewswire.com
3 Top Cannabis Stocks to Buy in February
February 21, 2021 |  msn.com
Cresco Labs Buys Verdant Creations' dispensaries
February 16, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

1.47 out of 5 stars

Medical Sector

528th out of 1,968 stocks

Drug Manufacturers - Specialty & Generic Industry

5th out of 61 stocks

Analyst Opinion: 4.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.76 (-5.50 %)
(As of 03/5/2021 08:28 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRLBF News and Ratings via Email

Sign-up to receive the latest news and ratings for CRLBF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cresco Labs (OTCMKTS:CRLBF) Frequently Asked Questions

Is Cresco Labs a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cresco Labs in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cresco Labs stock.
View analyst ratings for Cresco Labs
or view top-rated stocks.

What stocks does MarketBeat like better than Cresco Labs?

Wall Street analysts have given Cresco Labs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cresco Labs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cresco Labs?

Cresco Labs saw a decline in short interest in the month of February. As of February 12th, there was short interest totaling 441,400 shares, a decline of 65.8% from the January 28th total of 1,289,800 shares. Based on an average trading volume of 2,709,800 shares, the short-interest ratio is currently 0.2 days.
View Cresco Labs' Short Interest

How has Cresco Labs' stock price been impacted by Coronavirus (COVID-19)?

Cresco Labs' stock was trading at $3.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CRLBF stock has increased by 291.3% and is now trading at $13.07.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CRLBF?

7 Wall Street analysts have issued 12-month price objectives for Cresco Labs' shares. Their forecasts range from $4.20 to $33.50. On average, they expect Cresco Labs' stock price to reach $19.15 in the next year. This suggests a possible upside of 46.5% from the stock's current price.
View analysts' price targets for Cresco Labs
or view top-rated stocks among Wall Street analysts.

Who are Cresco Labs' key executives?

Cresco Labs' management team includes the following people:
  • Mr. Charles Bachtell, Co-Founder, CEO & Director (Age 43, Pay $663.7k)
  • Mr. Thomas J. Manning, Exec. Chairman (Age 64)
  • Mr. Dominic Anthony Sergi, Co-Founder & Director (Age 38)
  • Mr. Robert M. Sampson, Co-Founder & Director (Age 47)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 58)
  • Mr. David Ellis, Chief Operating Officer (Age 39)
  • Mr. Ty Gent, Chief Operating Officer (Age 62)
  • Ms. Brenna Albert CPA, Sr. VP & Controller of Accounting, Treasury & Tax
  • Mr. Mo Dastagir, Chief Information Officer (Age 44)
  • Jake Graves, Sr. Analyst of Investor Relations

Who are some of Cresco Labs' key competitors?

What is Cresco Labs' stock symbol?

Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF."

How do I buy shares of Cresco Labs?

Shares of CRLBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cresco Labs' stock price today?

One share of CRLBF stock can currently be purchased for approximately $13.07.

How many employees does Cresco Labs have?

Cresco Labs employs 2,000 workers across the globe.

What is Cresco Labs' official website?

The official website for Cresco Labs is www.crescolabs.com.

How can I contact Cresco Labs?

The company can be reached via phone at 312-929-0993.

This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.